about
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaCellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleTranslating Treg Therapy in Humanized MiceNew Insights about Treg and Th17 Cells in HIV Infection and Disease ProgressionRegulatory T cells: Mechanisms of suppression and impairment in autoimmune liver diseaseSpecificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerPlant sterols as anticancer nutrients: evidence for their role in breast cancerSafety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parametersTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeBoosting Tumor-Specific Immunity Using PDTEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cellsHapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunityTumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasisIn vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administrationIncreased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infectionT regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative markerNitric oxide is a key component in inflammation-accelerated tumorigenesis.Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-β1 in gastric cancer.FOXP3 promoter demethylation reveals the committed Treg population in humans.FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma modelTopical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients.T-cell activation promotes tumorigenesis in inflammation-associated cancer.Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancerSpontaneous regression of metastatic cancer cells in the lymph node: a case reportThe role of regulatory T cells in cancer.Prostate cancer and inflammation: the evidence.Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemiaAllogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.Therapeutic HPV DNA vaccines.Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulationPresence of FOXP3(+)Treg cells is correlated with colorectal cancer progression
P2860
Q24605861-C6087ADA-A233-4252-BE5E-52B7253F529EQ26745444-D753E231-22B9-4763-868C-71E0A04CA9AFQ26769734-39445766-9054-43A5-8008-183248887210Q26772335-F7042DBD-CEE8-4FDB-A532-4C13EBF53332Q26777036-184FB604-8FE4-4290-8564-704309394068Q26827787-AABB5DBE-18A0-4E5E-AE73-E1BA43ADE65DQ26853171-4DDF2ADD-5FBF-43CB-A993-97B08C7E765AQ26861053-FE7919A8-73A0-4766-AF6B-8C77EAFF5634Q27002602-FEC2D441-FF5E-43A7-8EE9-666B0CC4C8A5Q28066522-C8E32617-002A-4236-B292-84A8F8123FD2Q28067203-AB2E2820-6458-4BE0-8B8A-2987E82A0BAFQ28069422-D6AB9778-2CD1-4D4E-BFD1-6E4E425D47FBQ28209990-682BA0E9-426B-4134-BA58-91A1F52AB796Q28386617-88EBC823-300E-4E8E-BAA1-1292E3A8D84FQ28387629-875CBD7D-DB38-4573-8469-BDB3A7987155Q28507927-01155C99-FDC2-4D4F-A29A-3FC566FA1E2DQ28732675-F9C9FF4B-741D-44CB-984B-1CF5C7996799Q28748867-F1DFCDB1-20B7-4825-9F77-5EF6AC3DDEF6Q28748898-07D805AD-B35E-472D-B9BB-9403DD5A6B0CQ30438755-EAE6BBDE-94E9-472D-B7C3-5F5447C2E0E0Q31118578-1BD90260-8D66-475C-A1DA-8559EFBC8A53Q33320522-CA7618EF-B61D-4088-9E50-641604CBACD5Q33320890-D2051E0B-0DE1-43B5-9E54-BBF8592B37C8Q33527427-ECFD6D00-ECC9-4323-9A00-DCF8697EE3BDQ33563230-F12D71F4-C09A-435C-8E1E-90104C59EB4DQ33587584-FEB043B4-3F7A-4EE0-A7EC-3651AE4AD0DCQ33590130-32F69B06-D34E-4341-B823-062227D1BF3DQ33608626-7F48F4BD-73FF-4BCC-94D9-3C3827422CCBQ33629800-ADA1B112-8FA4-4A16-8116-F055655F6F7BQ33631986-3FA0D222-5D73-40AC-B314-C18B32A0E9D0Q33642321-4C7DB5EB-A0C9-44FF-BCE0-EDE7E676F7E7Q33688225-C8167519-2ADA-4421-B329-57B3F47666BDQ33722667-7333C99B-0C7C-47D4-96B9-0BB8889571E2Q33835381-EA4FD2E3-6967-4AF7-8ECE-FD9964BC3B59Q33892358-1EB86D4E-A1D3-4641-8DCD-033AFD8F2DD7Q33906361-52B5706C-B673-4C76-BBD0-5DA020B3F200Q33936427-F4636B46-33D2-486A-9187-2CE5C0EC3613Q34026203-BA2BEA54-2464-4D05-9483-405FBB2F7368Q34027988-258D2A8F-E47A-4FE5-915A-971FEEA896AFQ34042234-3B61B109-2640-4A74-826F-0A8612D28F04
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Regulatory T cells in cancer.
@ast
Regulatory T cells in cancer.
@en
Regulatory T cells in cancer.
@nl
type
label
Regulatory T cells in cancer.
@ast
Regulatory T cells in cancer.
@en
Regulatory T cells in cancer.
@nl
prefLabel
Regulatory T cells in cancer.
@ast
Regulatory T cells in cancer.
@en
Regulatory T cells in cancer.
@nl
P1433
P1476
Regulatory T cells in cancer.
@en
P2093
Marc Beyer
P304
P356
10.1182/BLOOD-2006-02-002774
P407
P577
2006-08-01T00:00:00Z